IN RECENT NEWS
"One interesting observation is that the only company listed in all three functional categories is Gestalt Diagnostics. This must be a market-winning business strategy for Gestalt Diagnostics, as it is the only digital pathology company on the list above to grow rapidly enough to have made Inc. Magazine’s 2023 “5000 Fastest Growing Private Companies in America.” - The Dark Report, September, 2024
Our Team
We are focused on leveraging our expertise and experience to deliver the highest quality solutions and services to our customers while leading the way with disruptive product innovation.
Gestalt team members bring a wealth of expertise in the healthcare, digital imaging, laboratory, and software industries to our customers and our company. Our team’s collective experience includes new product development, lean processes, award-winning service, and renowned industry leadership.
MEET OUR TEAM
Dan Roark
Chief Executive Officer
Mr. Roark is an experienced CEO, serial entrepreneur, active angel investor, and board member for technology businesses with experience in the life science industry and beyond.
Lisa-Jean Clifford
COO & Chief Strategy Officer
Lisa-Jean has more than twenty years of experience in high-tech industries with over 15 of them specifically in
healthcare high-tech.
Roopam Kakoti
CTO, Chief Technology Officer
Roopam has 20 years of experience in the software industry with a proven track record of building high-performance teams that have been focused on developing enterprise-level software.
Ethan Lynn
VP, Professional Services
Ethan has worked with dozens of anatomic pathology laboratories across the United States and Canada for the past 18 years, helping them to maximize return on their information systems and growing their business through IT solutions.
Brian Napora
VP, Innovation
Brian has been involved in process engineering and product development for nearly 20 years in the healthcare continuum in sales, IT management,
and software development.
Charles Best
Product Director, Digital Solutions
Charles has almost 15 years in the digital pathology space having held multiple roles encompassing applications, sales, and product development.
Board Members
Kenneth McCabe, MD
Ken McCabe is a neuro-radiologist with Inland Imaging. Ken is the former Chairman of Inland Imaging Investments.
Chris Patrick
Chris Patrick is the CEO of Inland Imaging, Inland Imaging Business Associates, and Inland Imaging Investments.
John Bell, MD
John Bell is the President of Inland Imaging Investments and a radiologist at Inland Imaging. He is also currently the Chairman of Nuvodia.
Wayne Wager
Wayne is an active entrepreneur and investor. In addition to providing substantial insights from over three decades of experience in medical technology and venture capital, Wayne has a seasoned grasp of the global healthcare environment.
Octavio Morales
Octavio is a proven industry executive with extensive accomplishments in the LAN, MAN, and Data Center markets - at the semiconductor, systems, and service provider levels. He has over 30 years of accomplishments at leading startups and established companies.
Tom Simpson
Executive Advisor
Tom has over 35 years of experience as an investment banker, venture capitalist, angel investor, and entrepreneur. He is the CEO of Ignite Northwest, President of the Spokane Angel Alliance, and Managing Member of Kick-Start angel investment funds.
Bill Driscoll
President of Tacoma Venture Fund, Driscoll also serves as Chairman and CEO of Clearwater Management Company, a registered investment adviser, as managing partner of Lincoln Park Partners, a private commercial real estate and management company, and on the board of PotlatchDeltic (NASDAQ) and as chair of its Nominating and Governance Committee.
Advisory Board
Eric Glassy, MD
Dr. Glassy is a community pathologist in Southern California and director of pathology at Providence Little Company of Mary Medical Center, San Pedro. He is a member of Affiliated Pathologists Medical Group, a 40-person independent pathology group covering 18 hospitals and laboratories in California, Portland, and Phoenix.
J. Mark Tuthill, MD
Dr. Tuthill is Division Head of Pathology Informatics at Henry Ford Health System. He advises the ASCP Annual Meeting, is a delegate for Wayne Medical Society and the CDC’s CLIAC, and directs the API Pathology Informatics Summit. Dr. Tuthill, a charter member of API, has served in various leadership roles.
Dylan Miller, MD
Dr. Miller is a Professor of Pathology at the University of Utah School of Medicine and practices in a private group at the Intermountain Medical Center in Salt Lake City. He is Chair of Pathology at Intermountain Central Laboratory, which serves Intermountain Healthcare’s statewide system of hospitals in Utah and neighboring states.
